Drug intelligence / Profile preview

metiram

Development stage
Unknown
Lead developer
BASF
Modality
Small Molecules
Administration
Topical
01

Overview

Metiram is a non-systemic, multi-site dithiocarbamate fungicide used in agriculture to control a broad spectrum of fungal diseases in crops such as grapes, potatoes, apples, and vegetables. It functions as a surface protectant by inhibiting fungal spore germination through the interference of various enzyme systems. Developed and marketed by BASF, metiram is frequently used in resistance management strategies due to its multi-site mode of action, which makes the development of fungal resistance less likely. However, recent regulatory reviews, notably by the European Food Safety Authority (EFSA), have identified metiram as an endocrine disruptor, leading to its non-approval or restricted use in certain jurisdictions. Its primary metabolite, ethylenethiourea (ETU), is a known toxicant associated with thyroid dysfunction and potential carcinogenicity.

Brand names
PolyramPolyram DF
Other names
zinc ammoniate ethylenebis(dithiocarbamate)-poly(ethylenethiuram disulfide)metiram TK

Beyond the preview

Go deeper on metiram.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metiram.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call